Literature DB >> 3001737

Evidence for rearrangement, amplification, and expression of c-myc in a human glioblastoma.

J Trent, P Meltzer, M Rosenblum, G Harsh, K Kinzler, R Mashal, A Feinberg, B Vogelstein.   

Abstract

Amplified cellular genes are frequently manifested in one of two cytologically recognizable forms, double minutes or homogeneously staining regions. Additionally, evidence is accumulating that aberrant expression of cellular genes (including oncogenes) may be mediated by gene amplification. We now describe the amplification and expression of the cellular oncogene c-myc in double-minute-containing cells from a patient with glioblastoma multiforme, and we have shown that the amplification is associated with rearrangement of the c-myc gene. This finding further supports the common association of the myc gene family in neurogenic tumors and provides evidence of myc gene amplification in human brain cancer.

Entities:  

Mesh:

Year:  1986        PMID: 3001737      PMCID: PMC322881          DOI: 10.1073/pnas.83.2.470

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  24 in total

1.  Detection of specific sequences among DNA fragments separated by gel electrophoresis.

Authors:  E M Southern
Journal:  J Mol Biol       Date:  1975-11-05       Impact factor: 5.469

2.  Metaphase chromosome anomaly: association with drug resistance and cell-specific products.

Authors:  J L Biedler; B A Spengler
Journal:  Science       Date:  1976-01-16       Impact factor: 47.728

3.  Ribonucleic acid isolated by cesium chloride centrifugation.

Authors:  V Glisin; R Crkvenjakov; C Byus
Journal:  Biochemistry       Date:  1974-06-04       Impact factor: 3.162

4.  Novel DNA rearrangements are associated with dihydrofolate reductase gene amplification.

Authors:  N A Federspiel; S M Beverley; J W Schilling; R T Schimke
Journal:  J Biol Chem       Date:  1984-07-25       Impact factor: 5.157

5.  Structure of amplified DNA in different Syrian hamster cell lines resistant to N-(phosphonacetyl)-L-aspartate.

Authors:  F Ardeshir; E Giulotto; J Zieg; O Brison; W S Liao; G R Stark
Journal:  Mol Cell Biol       Date:  1983-11       Impact factor: 4.272

Review 6.  Cellular oncogenes and retroviruses.

Authors:  J M Bishop
Journal:  Annu Rev Biochem       Date:  1983       Impact factor: 23.643

7.  Amplification, enhanced expression and possible rearrangement of EGF receptor gene in primary human brain tumours of glial origin.

Authors:  T A Libermann; H R Nusbaum; N Razon; R Kris; I Lax; H Soreq; N Whittle; M D Waterfield; A Ullrich; J Schlessinger
Journal:  Nature       Date:  1985 Jan 10-18       Impact factor: 49.962

8.  Rat insulin genes: construction of plasmids containing the coding sequences.

Authors:  A Ullrich; J Shine; J Chirgwin; R Pictet; E Tischer; W J Rutter; H M Goodman
Journal:  Science       Date:  1977-06-17       Impact factor: 47.728

9.  Chromosome localization in normal human cells and neuroblastomas of a gene related to c-myc.

Authors:  M Schwab; H E Varmus; J M Bishop; K H Grzeschik; S L Naylor; A Y Sakaguchi; G Brodeur; J Trent
Journal:  Nature       Date:  1984 Mar 15-21       Impact factor: 49.962

10.  Amplification of N-myc in untreated human neuroblastomas correlates with advanced disease stage.

Authors:  G M Brodeur; R C Seeger; M Schwab; H E Varmus; J M Bishop
Journal:  Science       Date:  1984-06-08       Impact factor: 47.728

View more
  50 in total

Review 1.  Molecular genetics of neurological tumours.

Authors:  R Y Chung; B R Seizinger
Journal:  J Med Genet       Date:  1992-06       Impact factor: 6.318

2.  Interspecies comparison of c-myc gene in human and rat glioma cell lines.

Authors:  H Shindo; E Tani; N Kochi; K Kaba; T Matsumoto; K Miyaji; Y Yamamoto; J Furuyama
Journal:  Acta Neuropathol       Date:  1991       Impact factor: 17.088

3.  Establishment and characterization of five cell lines derived from human malignant gliomas.

Authors:  J T Rutka; J R Giblin; D Y Dougherty; H C Liu; J R McCulloch; C W Bell; R S Stern; C B Wilson; M L Rosenblum
Journal:  Acta Neuropathol       Date:  1987       Impact factor: 17.088

4.  Changes in glial fibrillary acidic protein and karyotype during culturing of two cell lines established from human glioblastoma multiforme.

Authors:  V Bocchini; R Casalone; P Collini; G Rebel; F Lo Curto
Journal:  Cell Tissue Res       Date:  1991-07       Impact factor: 5.249

5.  Myc regulates a transcriptional program that stimulates mitochondrial glutaminolysis and leads to glutamine addiction.

Authors:  David R Wise; Ralph J DeBerardinis; Anthony Mancuso; Nabil Sayed; Xiao-Yong Zhang; Harla K Pfeiffer; Ilana Nissim; Evgueni Daikhin; Marc Yudkoff; Steven B McMahon; Craig B Thompson
Journal:  Proc Natl Acad Sci U S A       Date:  2008-11-24       Impact factor: 11.205

6.  Chromosomal destabilization during gene amplification.

Authors:  J C Ruiz; G M Wahl
Journal:  Mol Cell Biol       Date:  1990-06       Impact factor: 4.272

7.  Overexpression of c-MYC promotes an undifferentiated phenotype in cultured astrocytes and allows elevated Ras and Akt signaling to induce gliomas from GFAP-expressing cells in mice.

Authors:  Andrew B Lassman; Chengkai Dai; Gregory N Fuller; Andrew J Vickers; Eric C Holland
Journal:  Neuron Glia Biol       Date:  2004-05

8.  Amplified human MYC oncogenes localized to replicating submicroscopic circular DNA molecules.

Authors:  D D Von Hoff; D R Needham-VanDevanter; J Yucel; B E Windle; G M Wahl
Journal:  Proc Natl Acad Sci U S A       Date:  1988-07       Impact factor: 11.205

Review 9.  Genetic alterations in glioma and medulloblastoma.

Authors:  B K Rasheed; S H Bigner
Journal:  Cancer Metastasis Rev       Date:  1991-12       Impact factor: 9.264

10.  Increased expression of the epidermal growth factor receptor gene in malignant gliomas is invariably associated with gene amplification.

Authors:  A J Wong; S H Bigner; D D Bigner; K W Kinzler; S R Hamilton; B Vogelstein
Journal:  Proc Natl Acad Sci U S A       Date:  1987-10       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.